Updated: January 17, 2026

Alternatives to Qsymia If You Can't Fill Your Prescription

Author

Peter Daggett

Summarize with AI

Why Patients Need Alternatives to Qsymia
Alternative #1: Phentermine + Topiramate (Prescribed Separately)
Alternative #2: Contrave (Naltrexone/Bupropion ER)
Alternative #3: Wegovy (Semaglutide) or Ozempic Off-Label
Alternative #4: Zepbound (Tirzepatide)
Alternative #5: Orlistat (Xenical / Alli)
Comparing Qsymia to Its Alternatives
Talk to Your Provider Before Switching

Can't find Qsymia at a pharmacy near you? These proven weight-loss alternatives may be easier to access and just as effective for many patients.

Qsymia (phentermine/topiramate extended-release) is one of the most effective oral weight-loss medications available, but its REMS distribution restrictions mean not everyone can easily fill a prescription. If you've hit a wall trying to find Qsymia in stock—or if cost, insurance, or medical reasons make it inaccessible for you—there are solid alternatives worth discussing with your provider.

Here's a practical breakdown of the most commonly prescribed weight-loss medications that could work if Qsymia isn't an option for you right now.

Why Patients Need Alternatives to Qsymia

There are several reasons you might need to switch from Qsymia or consider it from the start:

No REMS-certified pharmacy near you

Cost is prohibitive even with discount programs

You are pregnant or planning to become pregnant (Qsymia is contraindicated)

Insurance won't cover it and you need a covered alternative

Side effects like insomnia, dizziness, or paresthesia are intolerable

Your state restricts controlled-substance discount coupons, limiting savings options

Alternative #1: Phentermine + Topiramate (Prescribed Separately)

The same two ingredients in Qsymia can be prescribed as separate generic medications, avoiding the REMS program entirely. Generic phentermine is widely available at most pharmacies for roughly $10–$30 per month. Generic topiramate (immediate-release, not extended-release) is also readily available for about $15–$25 per month. Combined, you may get similar benefits at $15–$50 per month with no REMS restrictions.

The tradeoff: separate prescribing is off-label, the dosing and titration are different from Qsymia's formulation, and you won't have the convenience of a single extended-release capsule. Discuss this approach carefully with your prescriber.

Alternative #2: Contrave (Naltrexone/Bupropion ER)

Contrave combines naltrexone (an opioid antagonist) and bupropion (an antidepressant/smoking cessation drug) in an extended-release tablet. It works by targeting the brain's reward and hunger pathways. Key advantages over Qsymia:

No REMS program required—available at virtually any pharmacy

Not a controlled substance

Generic version available for $50–$150/month, often covered by insurance

May be particularly helpful for patients with food cravings or emotional eating patterns

Average weight loss with Contrave is approximately 5–6% of body weight over 56 weeks, compared to up to 10% with Qsymia at the maximum dose. It's contraindicated in patients with seizure disorders or those using opioids.

Alternative #3: Wegovy (Semaglutide) or Ozempic Off-Label

Wegovy (semaglutide 2.4 mg weekly injection) is a GLP-1 receptor agonist approved specifically for weight management. Clinical trials show average weight loss of 15–17% of body weight—substantially more than Qsymia or Contrave. No REMS is required. Key considerations:

Weekly self-injection (some patients prefer pills)

List price is significantly higher than Qsymia; insurance coverage varies widely

Has demonstrated cardiovascular benefits in people with existing heart disease

Common side effects: nausea, vomiting, diarrhea (especially at initiation)

Alternative #4: Zepbound (Tirzepatide)

Zepbound (tirzepatide) is a dual GLP-1/GIP receptor agonist—currently among the most effective weight-loss medications available. Clinical trials showed average weight loss of 20–22% of body weight at the highest dose. Like Wegovy, it's a weekly injection. It's more effective than Qsymia for most patients, but cost and insurance coverage remain significant barriers for many.

Alternative #5: Orlistat (Xenical / Alli)

Orlistat works differently from appetite suppressants—it blocks the absorption of dietary fat in the gut. Alli (the OTC 60 mg version) is available without a prescription at most pharmacies. Prescription-strength orlistat (Xenical, 120 mg) requires a prescription. Average weight loss is modest (3–5%), and GI side effects (oily stools, frequent bowel movements) can be significant if dietary fat intake is high. However, it's widely available and doesn't carry any of Qsymia's REMS or controlled-substance restrictions.

Comparing Qsymia to Its Alternatives

Qsymia (15/92 mg): ~10% body weight loss; oral; REMS-restricted; $63–$149/month with discounts

Phentermine + Topiramate (separate generics): Similar mechanism; no REMS; ~$15–$50/month

Contrave (generic): ~5–6% body weight loss; oral; no REMS; $50–$150/month

Wegovy (semaglutide): ~15–17% body weight loss; weekly injection; no REMS; higher cost

Zepbound (tirzepatide): ~20–22% body weight loss; weekly injection; no REMS; higher cost

Orlistat (Alli OTC): ~3–5% body weight loss; oral; available OTC; $40–$60/month

Talk to Your Provider Before Switching

No two patients are alike. The best alternative for you depends on your health history, any other medications you take, your insurance plan, and your weight loss goals. Talk with your prescriber before making any changes. And if you want to try one more time to locate Qsymia before switching, medfinder can help find a certified pharmacy that has it in stock near you.

Frequently Asked Questions

The best alternative depends on your health profile. Contrave (naltrexone/bupropion) is the most similar oral option without REMS restrictions, costing $50–$150/month for the generic. GLP-1 receptor agonists like Wegovy or Zepbound produce greater weight loss (15–22% of body weight) but require weekly injections and often have higher costs.

Yes, some providers prescribe generic phentermine and generic topiramate separately as an off-label alternative to Qsymia. This approach avoids the REMS program and can cost as little as $15–$50 per month combined. However, the formulations differ (immediate-release vs. extended-release), so the dosing strategy is different. Discuss this option with your prescriber.

Contrave typically produces 5–6% body weight loss over one year, compared to approximately 8–10% with Qsymia at recommended doses. Qsymia tends to be more effective for most patients, but Contrave has the advantage of no REMS restrictions, no controlled-substance classification, and is available at virtually any pharmacy.

Yes, Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for weight management and are available without REMS restrictions. They are weekly injections and tend to produce greater weight loss than Qsymia (15–22% vs. ~10%), but they are typically more expensive and require insurance coverage or significant out-of-pocket spending.

No OTC medication works through the same mechanism as Qsymia. However, orlistat (sold as Alli OTC at 60 mg) is an FDA-approved non-prescription weight loss aid that blocks fat absorption. It produces modest results (3–5% weight loss) compared to Qsymia, but is widely available without a prescription or REMS restrictions.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards